Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Demonstrating another key achievement, Microbot Medical Inc. (Nasdaq: MBOT), continues to execute its objective of expanding its global intellectual property (IP) portfolio for the LIBERTY® Robotic System as a grant for two Design Patent Applications was issued by the European Patent Office (EPO), covering the LIBERTY Robotic System’s Robotic Drive and Remote Controller.

“The innovative nature of the LIBERTY Robotic System continues to be recognized by global jurisdictions and reflected in our continuing ability to secure a sustainable competitive advantage by growing our Intellectual Property portfolio,” commented Harel Gadot, Chairman, CEO and President. “This will allow us to continue leveraging our core capabilities to support our vision to allow accessibility to robotics and meet the demand of physicians, hospitals and patients.”

About Microbot Medical

Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot’s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).

Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available at http://www.microbotmedical.com.

Safe Harbor

Statements to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects” and “estimates”) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent in the development and/or commercialization of potential products, including LIBERTY and SCS, the outcome of its studies to evaluate LIBERTY, SCS and other existing and future technologies, any failure or inability to recruit physicians and clinicians to serve as primary investigators to conduct the SCS’s early feasibility study which could adversely affect or delay such study, uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading “Risk Factors” in Microbot Medical’s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC’s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Investor Contact:

Michael Polyviou
EVC Group
mpolyviou@evcgroup.com
732-933-2754

Staff

Recent Posts

Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select…

7 hours ago

Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event

Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and…

1 day ago

Sage Healthspan Launches AI-Powered, Privacy-First Wellness App to Bridge Critical Gaps in Preventative Healthcare

Orange County, California, June 27, 2025 (GLOBE NEWSWIRE) -- Sage Healthspan, a California-based digital health…

1 day ago

theranos Calls on President Trump to Pardon Elizabeth Holmes

You Cannot Silence the SciencePALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- In less…

1 day ago